scPharmaceuticals Inc (SCPH)
4.74
-0.08
(-1.76%)
USD |
NASDAQ |
May 17, 16:00
4.74
0.00 (0.00%)
After-Hours: 20:00
scPharmaceuticals Profit Margin (Quarterly): -231.2% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -231.2% |
December 31, 2023 | -226.6% |
September 30, 2023 | -411.9% |
Date | Value |
---|---|
June 30, 2023 | -864.1% |
March 31, 2023 | -543.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-864.1%
Minimum
Jun 2023
-226.6%
Maximum
Dec 2023
-455.4%
Average
-411.9%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
Anika Therapeutics Inc | -11.14% |
Spero Therapeutics Inc | 71.27% |
electroCore Inc | -64.41% |
NovaBay Pharmaceuticals Inc | -122.2% |
Palatin Technologies Inc | -385.6% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -115.3% |
Return on Assets | -55.43% |
Return on Invested Capital | -65.34% |
Gross Profit Margin (Quarterly) | 70.75% |
Operating Margin (Quarterly) | -259.8% |
Return on Net Operating Assets | -411.4% |